Details for New Drug Application (NDA): 060751
✉ Email this page to a colleague
NDA 060751 describes NEO-CORTEF, which is a drug marketed by Pharmacia And Upjohn and is included in four NDAs. Additional details are available on the NEO-CORTEF profile page.
The generic ingredient in NEO-CORTEF is hydrocortisone acetate; neomycin sulfate. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; neomycin sulfate profile page.
The generic ingredient in NEO-CORTEF is hydrocortisone acetate; neomycin sulfate. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; neomycin sulfate profile page.
Summary for 060751
| Tradename: | NEO-CORTEF |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | hydrocortisone acetate; neomycin sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.5%;EQ 3.5MG BASE/GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 1%;EQ 3.5MG BASE/GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 2.5%;EQ 3.5MG BASE/GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
